Congress meeting · Dr. Valentina Hayashi

24 Jun 2026 · Virtual · Dr. Valentina Hayashi, Hospital Clínic Barcelona · MSL Rachel Adeyemi · Vantrexa

ReviewedVeeva CRMENG-0017—

Topics discussed

What is the evidence for re-challenge with checkpoint inhibitors after progression on vantrelimab?

Congress meeting with oncology pharmacist at Hospital Clínic Barcelona. Discussed chemotherapy-free first line.

INS-0017High
Chemotherapy-free first line
Chemotherapy-free first line: practice variation observed reported by oncology pharmacist (ES).
Deduplicated

Review complete. Quality ratings and insights can now be used in aggregates.

0 of 1 complete

1–5, rated at review

All create, update and approval events for this record

Time	Action	User	Field	Change	Reason	Source
12 Sept 2026, 13:57 UTC	Update	PRDr. Priya Raman	dueDate	Planned → In progress	—	UI